Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for trovafloxacin (compound)
Most Correlated Studies
- HCC Hep G2 cells with nimesulide, nefazodone, trovafloxacin, aspirin, buspirone or levofloxacin
- Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
- Comparison of primary human hepatocytes to Hep G2 cells treated with fluoroquinolone compounds
- Hepatocyte gene expression profiles in response to the topoisomerase inhibitor trovafloxacin
- Liver Pharmacology and Xenobiotic Response Repertoire
Most Relevant Literature
- Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macro…
- TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
- Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine…
- MicroRNA-877-5p is involved in the trovafloxacin-induced liver injury.
- UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
Most Relevant Clinical Trials
- Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
- Maintenance Dovitinib for Colorectal and Pancreas Cancer
- Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Di…
- Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
- Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Ch…
